MYASTHENIA GRAVIS, GENERALIZED
Clinical trials for MYASTHENIA GRAVIS, GENERALIZED explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS, GENERALIZED trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, GENERALIZED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ravulizumab tracked in Real-World MG study
Disease control Recruiting nowThis study follows 50 adults in Poland with generalized myasthenia gravis (gMG) who are taking ravulizumab for the first time. Researchers will track how well the drug improves daily activities and symptoms over time. The goal is to see how ravulizumab works in real-world setting…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 16, 2026 23:32 UTC
-
New drug trial aims to tame muscle weakness in myasthenia gravis
Disease control Recruiting nowThis study tests an investigational drug called povetacicept in 30 adults with generalized myasthenia gravis, a condition causing muscle weakness. The goal is to see if the drug safely lowers certain immune proteins (IgG) linked to the disease. Participants receive either the dru…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated May 16, 2026 23:31 UTC
-
New hope for seniors: drug may cut harmful steroids in Muscle-Weakening disease
Disease control Recruiting nowThis study looks at whether efgartigimod, a newer medication, can help people aged 65 and older with generalized myasthenia gravis lower their dose of steroids. Steroids can cause serious side effects, especially in older adults. The goal is to see if efgartigimod can control the…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Massive study aims to unlock secrets of brain inflammation diseases
Knowledge-focused Recruiting nowThis study is collecting health information from up to 10,000 people with conditions like Long COVID, ME/CFS, and autoimmune diseases. Participants use a smartphone app to share symptoms, health history, and wearable data. The goal is to better understand these illnesses and help…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC